EI
ENTA icon

Ellevest Inc’s Enanta Pharmaceuticals ENTA Stock Holding History

Ellevest Inc’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-79
Closed -$4K – 1879
2022
Q3 		$4K Sell
79
-171
-68% -$9.99K ﹤0.01% 1214
2022
Q2 		$12K Buy
250
+74
+42% +$4.02K ﹤0.01% 848
2022
Q1 		$13K Sell
176
-32
-15% -$2.08K ﹤0.01% 825
2021
Q4 		$16K Sell
208
-29
-12% -$2.28K ﹤0.01% 759
2021
Q3 		$13K Sell
237
-128
-35% -$6.33K ﹤0.01% 773
2021
Q2 		$16K Buy
365
+45
+14% +$2.2K ﹤0.01% 675
2021
Q1 		$16K Buy
320
+96
+43% +$4.79K ﹤0.01% 700
2020
Q4 		$9K Buy
224
+166
+286% +$7.3K ﹤0.01% 751
2020
Q3 		$3K Buy
58
+2
+4% +$97 ﹤0.01% 834
2020
Q2 		$3K Hold
56
– – ﹤0.01% 814
2020
Q1 		$3K Buy
+56
New +$2.98K ﹤0.01% 702

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Ellevest Inc's ENTA Position: Q4 2022 in Review

Ellevest Inc sold out of Enanta Pharmaceuticals (ENTA) in Q4 2022, closing a stake of 79 shares — an estimated $4K sold.

Ellevest Inc first reported a position in ENTA in Q1 2020 and held it in 11 quarters. The position peaked at $16K in Q4 2021. 146 funds tracked by Wall St. Rank hold ENTA as of Q4 2022.

  • Ellevest Inc reported no remaining Enanta Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Ellevest Inc sold 79 Enanta Pharmaceuticals shares in Q4 2022, an estimated $4K.
  • Ellevest Inc first reported a position in Enanta Pharmaceuticals in Q1 2020 and held it in 11 quarters.
  • Ellevest Inc's Enanta Pharmaceuticals position peaked at $16K in Q4 2021.
  • 146 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.